tradingkey.logo

Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product Designation

ReutersFeb 23, 2026 12:27 PM

- Armata Pharmaceuticals Inc ARMP.A:

  • ARMATA PHARMACEUTICALS RECEIVES FDA QUALIFIED INFECTIOUS DISEASE PRODUCT (QIDP) DESIGNATION FOR AP-SA02

  • ARMATA: PLANS TO ADVANCE AP-SA02 INTO PHASE 3 SUPERIORITY STUDY IN COMPLICATED S. AUREUS BACTEREMIA, ANTICIPATED TO INITIATE IN SECOND HALF OF 2026

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI